![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 25, 22271-22278, June 21, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
, andFrom the Department of Microbiology and Molecular Genetics and the Molecular Biology Institute, University of California, Los Angeles, California 90095, § Centre de Recherche en Cancerologie, Pavillon Hotel-Dieu de Quebec, CHUQ Quebec GIR 2J6, Canada, and ¶ Institute of Medical Radiobiology of the University of Zürich and the Paul Scherrer institute, August Forel-Strasse 7, CH-8008 Zürich, Switzerland
Received for publication, February 22, 2002, and in revised form, March 27, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Proliferating cell nuclear antigen
(PCNA) acts as a sliding clamp on duplex DNA. Its homologs, present in
Eukarya and Archaea, are part of protein complexes that are
indispensable for DNA replication and DNA repair. In Eukarya, PCNA is
known to interact with more than a dozen different proteins, including
a human major nuclear uracil-DNA glycosylase (hUNG2) involved in
immediate postreplicative repair. In Archaea, only three classes of
PCNA-binding proteins have been reported previously: replication factor
C (the PCNA clamp loader), family B DNA polymerase, and flap
endonuclease. In this study, we report a direct interaction between a
uracil-DNA glycosylase (Pa-UDGa) and a PCNA homolog
(Pa-PCNA1), both from the hyperthermophilic crenarchaeon
Pyrobaculum aerophilum (Topt = 100 °C). We
demonstrate that the Pa-UDGa-Pa-PCNA1 complex
is thermostable, and two hydrophobic amino acid residues on
Pa-UDGa (Phe191 and Leu192) are
shown to be crucial for this interaction. It is interesting to note
that although Pa-UDGa has homologs throughout the Archaea and bacteria, it does not share significant sequence similarity with
hUNG2. Nevertheless, our results raise the possibility that Pa-UDGa may be a functional analog of hUNG2 for
PCNA-dependent postreplicative removal of
misincorporated uracil.
Proliferating cell nuclear antigen
(PCNA)1 is essential for
life. It is a processivity factor for DNA polymerase, forming a toroidal-shaped trimer acting as a sliding clamp on duplex DNA (1-4).
Its function requires another protein, the clamp loader replication
factor C, to load it onto the circular DNAs (5-9). PCNA is present in
eukaryotes and its functional analog, the Recently PCNA sequence homologs have been identified in Archaea (21,
22). So far, each of the 10 completely sequenced archaeal genomes
contains at least one putative PCNA homolog (23). There is a
distinction found between the two major subdomains of the Archaea,
Crenarchaeota and Euryarchaeota (23). Whereas each euryarchaeal genome
tends to have one PCNA homolog, each crenarchaeal genome has two or
three putative PCNA homologs (21, 23, 24). Biochemical studies have
been conducted with several of the archaeal PCNA homologs, including a
PCNA homolog from the euryarchaeote Pyrococcus furiosus and
two PCNA homologs from the crenarchaeote Sulfolobus
solfataricus (21, 22). These studies have confirmed that all of
them are processivity factors for their corresponding DNA polymerases.
In Archaea, in addition to the PCNA clamp loader (replication factor
C), two classes of archaeal proteins have so far been identified as
PCNA-binding proteins, based on in vitro binding study and
crystal structure analysis. They are family B DNA polymerase (Pol B)
(22) and flap endonuclease (FEN) (25-29), both proteins known to
interact with PCNA in eukaryotes. The proposed putative PCNA-binding
motifs in these archaeal PCNA-binding proteins are quite similar to the
conserved PCNA-binding motif identified in eukaryotic PCNA-binding
proteins (22, 27). However, these putative PCNA binding sites have not
been verified by mutation analysis.
In this study, we report identification of another archaeal
PCNA-binding protein, Pyrobaculum aerophilum uracil-DNA
glycosylase (Pa-UDGa), and the biochemical confirmation of
its interaction with PCNA via the PCNA-binding motif. P. aerophilum is a hyperthermophile with an optimal growth
temperature of 100 °C and a member of the crenarchaeal subdomain of
Archaea (30). The biochemical characterization of uracil-DNA
glycosylase activity of Pa-UDGa was recently published (31).
Analysis of the complete genome sequence of P. aerophilum revealed two putative PCNA homologs (24),
Pa-PCNA1 and Pa-PCNA2, as expected for a
crenarchaeote (23). We demonstrate that Pa-UDGa preferentially binds to Pa-PCNA1, similar to two other
P. aerophilum PCNA-binding proteins,
Pa-FEN and P. aerophilum DNA polymerase B3
(Pa-Pol B3). Pa-UDGa's ability to bind to
Pa-PCNA1 resembles the eukaryotic PCNA-binding protein
hUNG2, which belongs to a distinctly different UDG family due to low
amino acid sequence similarity to Pa-UDGa. Our results raise
the possibility that Pa-UDGa may be a functional analog of
hUNG2 for PCNA-dependent postreplicative removal of
misincorporated uracil.
Bacterial Expression Plasmids--
P. aerophilum
genomic DNA was prepared as described previously (32). The coding
regions for Pa-UDGa (PAE0651, Protein Data Bank
accession number AAL62921) and Pa-FEN (PAE0698, Protein Data
Bank accession number AAL62961) were amplified by PCR using
P. aerophilum genomic DNA as template with their
corresponding primer pairs. The PCR products were cloned into a
pCR2.1-TOPO vector using a TOPO TA cloning kit (Invitrogen). The primer
information can be obtained upon request.
The full-length Pa-UDGa gene was amplified by PCR using
pCR2.1TOPOPa-UDGa as template, cloned into a pGEX-2TK vector
(Amersham Biosciences) at the BamHI site to create a
plasmid that expresses a fusion protein of glutathione
S-transferase (GST) and Pa-UDGa. The full-length
Pa-FEN gene was amplified by PCR using
pCR2.1TOPOPa-FEN as template and cloned into a pGEX-2TK
vector (Amersham Biosciences) at the EcoRI site to create a
plasmid that expresses GST-Pa-FEN fusion protein. Two
Pa-Pol B3 (PAE2109, Protein Data Bank accession number
AAL63952) fragments containing the carboxyl-terminal region (C1: amino
acid residues 612-785, and C2: amino acid residues 726-785) were
amplified by PCR using P. aerophilum genomic DNA as
template, cloned into a pGEX-2TK vector (Amersham Biosciences) between the BamHI and EcoRI sites to create two
plasmids that express GST-Pa-Pol B3 (C1: amino acids
612-785) fusion and GST-Pa-Pol B3 (C2: amino acids
726-785) fusion, respectively. The full-length Pa-PCNA1
gene (PAE3038, Protein Data Bank accession number AAL64629) was
amplified by PCR using P. aerophilum genomic DNA, cloned
into a pQE30 vector (Qiagen, Chatsworth, CA) between the
BamHI and HindIII sites to create a plasmid that
expresses the amino-terminal hexahistidine-tagged Pa-PCNA1.
The full-length Pa-PCNA2 gene (PAE0720, Protein Data Bank
accession number AAL62977) was amplified by PCR using P. aerophilum genomic DNA, cloned into a pQE30 vector (Qiagen)
between the SphI and SalI sites to create a
plasmid that expresses the amino-terminal hexahistidine-tagged
Pa-PCNA2. The murine PCNA (33) was subcloned into
a pBluescriptII KS vector (Stratagene, La Jolla, CA) between the
BamHI and EcoRI sites. Subsequently, the
BamHI-HindIII fragment was subcloned into a pQE30
vector (Qiagen) between the BamHI and HindIII
sites to create a plasmid that expresses the amino-terminal
hexahistidine-tagged murine PCNA.
For thermostable binding assays, the BamHI-BamHI
fragment of Pa-UDGa was subcloned into pQE30 vector (Qiagen)
to create a plasmid (pQE30Pa-UDGa) that expresses an
amino-terminal hexahistidine-tagged Pa-UDGa recombinant
protein. The BamHI-HindIII fragment of
Pa-PCNA1 was subcloned into a pQE60 vector (Qiagen) to
create a plasmid (pQE60Pa-PCNA1) that expresses the native
form of Pa-PCNA1 without the histidine tag.
Generation of Pa-UDGa and Pa-FEN Mutants--
The amino acid
fragments of Pa-UDGa 1-182, 131-196, and 172-196 were
amplified by PCR using pCR2.1TOPOPa-UDGa as template. The
products were subcloned into a pGEX-2TK vector (Amersham Biosciences) at the BamHI site to create GST fusion protein expression plasmids.
The Pa-UDGa mutant F183A/F184A was generated by standard
site-directed mutagenesis procedure (34) using
pCR2.1TOPOPa-UDGa as template. The obtained PCR products
were cloned into a pGEX-2TK vector (Amersham Biosciences) at the
BamHI site to create an expression plasmid for
GST-Pa-UDGa (F183A/F184A), and the mutations were verified
by DNA sequencing using a SequiTherm EXCEL II DNA sequencing kit
(Epicentre, Madison, WI).
The Pa-UDGa mutant F191A/L192A was generated by
site-directed mutagenesis. The PCR products were first cloned into a
pCR2.1-TOPO vector using a TOPO TA cloning kit (Invitrogen). The
BamHI-BamHI fragment containing the full-length
Pa-UDGa with two amino acid substitutions was subcloned into
a pGEX-2TK vector (Amersham Biosciences) at the BamHI site
to create an expression plasmid for GST-Pa-UDGa (F191A/L192A), and the mutations were verified by DNA sequencing using
a SequiTherm EXCEL II DNA sequencing kit (Epicentre).
The Pa-FEN mutant F345A/F346A was generated by site-directed
mutagenesis. The PCR products were first cloned into a pCR2.1-TOPO vector using a TOPO TA cloning kit (Invitrogen). The
EcoRI-EcoRI fragment containing the full-length
Pa-FEN with two amino acid substitutions was subcloned into
a pGEX-2TK vector (Amersham Biosciences) at the EcoRI site
to create an expression plasmid for GST- Pa-FEN (F345A/F346A), and the mutations were verified by DNA sequencing using
a SequiTherm EXCEL II DNA sequencing kit (Epicentre).
Expression and Partial Purification of Recombinant PCNA
Homologs--
Overnight cultures of Escherichia coli
BL21/pREP4 harboring plasmid pQE30 Pa-PCNA1, pQE30
Pa-PCNA2, or pQE30 murinePCNA were used to inoculate 100 ml of LB medium supplemented with 200 µg/ml ampicillin and 25 µg/ml
kanamycin. The expression of Pa-PCNA1, Pa-PCNA2,
or murine PCNA was induced with 0.3 mM
isopropyl-
A native Pa-PCNA1 recombinant protein without the histidine
tag was obtained for the thermostable binding assay by a similar protocol as described above. An E. coli strain BL21/pREP4
harboring plasmid pQE60Pa-PCNA1 was used for the preparation
of cell lysates. Subsequently, a heat treatment procedure was
applied to the cell lysates to obtain a partial purified recombinant
Pa-PCNA1 in its native form without the histidine tag.
Expression, Immobilization of GST Fusion Proteins, and
"Pull-down" Affinity Bead Interaction Assay--
E.
coli BL21 strain was used as the host to express all GST fusion
proteins and the GST protein. The cell lysates were prepared in buffer
A as described above. Protein concentration of the cell lysate was
determined by Bradford protein assay (Bio-Rad). Cell lysates were
incubated with the affinity matrices (GST-Sepharose beads, Amersham
Biosciences) for 1 h at 4 °C. After extensive washing with
buffer A, GST-Sepharose beads with immobilized GST fusion proteins were
stored in buffer A at 4 °C. To determine the amount of each
GST fusion protein bound for the pull-down assay, a fraction of
GST-Sepharose bead-immobilized proteins was released by boiling in SDS
sample buffer, analyzed by SDS-PAGE, and visualized by Coomassie
Brilliant Blue staining.
The amount of each GST fusion protein bound used for the pull-down
assay was adjusted for each sample based on the amount of bound
proteins analyzed by SDS-PAGE. Extra GST-Sepharose beads were added to
samples to bring the final amount of 60 µl. GST-Sepharose beads were
mixed with PCNA samples at 4 °C for 1h. After washing six times with
0.8 ml of buffer A, the bound proteins were released by boiling in 60 µl of SDS sample buffer, analyzed by SDS-PAGE, and transferred to
nitrocellulose membrane. Western blot analysis for Pa-PCNA
homologs were performed using the manufacturer's protocols (Qiagen)
with mouse anti-RGS(H)4 primary antibody (1:500) and horseradish peroxidase-conjugated secondary antibody (1:5000) followed
by ECL detection (Amersham Biosciences).
Thermostable Binding Assay--
An amino-terminal
hexahistidine-tagged Pa-UDGa protein was expressed in an
E. coli BL21/pREP4/pQE30Pa-UDGa strain, and the cell lysate was prepared by sonication in buffer B (50 mM
sodium phosphate, pH 8.0, 300 mM NaCl, supplemented with 1 mM phenylmethylsulfonyl fluoride). To immobilize
Pa-UDGa, Ni2+-NTA beads were added to the cell
lysate and incubated at 4 °C for 1 h. After extensive washing
with the buffer B, the Ni2+-NTA beads were transferred to
buffer A. The Ni2+-NTA beads (60 µl) containing
immobilized Pa-UDGa were mixed with the partial purified
recombinant Pa-PCNA1 in its native form or with E. coli cell lysate containing pQE30 vector alone after 70 °C heat
treatment. As a control for the experiment, a sample containing the
partial purified Pa-PCNA1 and 60 µl of
Ni2+-NTA beads without immobilized Pa-UDGa was
also prepared. After washing five times with 0.8 ml of buffer A at
4 °C, the Ni2+-NTA beads were evenly split into two
tubes. While one tube was incubated at 70 °C in a water bath for 5 min with 0.8 ml of buffer A pre-equilibrated at 70 °C, the other
tube was kept on ice with 0.8 ml of chilled buffer A. Ni2+-NTA beads were pelleted at 1000 × g
for 2 min. Bound proteins were released by boiling in SDS sample
buffer, analyzed by SDS-PAGE, and visualized by Coomassie Brilliant
Blue staining.
Expression and Partial Purification of Two Putative PCNA Homologs
from P. aerophilum--
As a member of the archaeal subdomain
Crenarchaeota, P. aerophilum contains two putative PCNA
homologs, Pa-PCNA1 and Pa-PCNA2, identified by amino acid sequence homology (Fig.
1A; see also Ref. 24).
Pa-PCNA1 shares 24% amino acid sequence identity with Pa-PCNA2 (Fig. 1B). The amino acid sequence
identities between the two putative Pa-PCNA homologs and the
other characterized eukaryotic or archaeal PCNAs range from 17 to 26%
(Fig. 1B). Both putative Pa-PCNA homologs
contain the highly conserved (L/I)AP(K/R) motif located near the
carboxyl terminus, which may interact with the clamp loader,
replication factor C (23). Phylogenetic analysis of PCNA homologs in
Crenarchaea reveals that the multiple homologs in Crenarchaea fall into
two classes, consistent with a duplication event early after the
divergence of the crenarchaeal clade (23).
Pa-PCNA1 and Pa-PCNA2 were cloned on the
bacterial expression vector pQE30 and expressed as amino-terminal
hexahistidine-tagged recombinant proteins in E. coli (Fig.
2, A and B,
lanes 3 and 5). To obtain partially purified
recombinant Pa-PCNA homologs for in vitro binding
assays, we took advantage of the heat stability characteristic of
proteins from thermophiles and heated the E. coli crude cell
lysates expressing each homolog to 70 °C. The recombinant
Pa-PCNA1 and Pa-PCNA2 were largely heat-stable
after a 10-min heat treatment (Fig. 2, A and B,
lanes 4 and 6). A hexahistidine-tagged eukaryotic
murine PCNA recombinant protein was also included in the experiment and
was found to be heat-labile under the conditions tested (Fig. 2,
A and B, lanes 7 and 8).
Although the recombinant Pa-PCNA1 and Pa-PCNA2
have predicted molecular masses of 28 and 29 kDa, respectively, the
apparent molecular mass on the SDS-polyacrylamide gel was ~37 kDa for
Pa-PCNA1 and 32 kDa for Pa-PCNA2. The aberrant migration of Pa-PCNAs on the SDS-polyacrylamide gel was also
seen in two S. solfataricus PCNAs (21) and
eukaryotic PCNA homologs (Fig. 2A, lane 7; see
also Ref. 35) for unknown reasons.
In Vitro Direct Binding of Pa-Pol B3 to
Pa-PCNA1--
Pa-Pol B3 was tested for binding to
recombinant Pa-PCNA1 and Pa-PCNA2. Analysis of
the Pa-Pol B3 protein sequence revealed that its
carboxyl-terminal region contains a putative PCNA-binding motif 778ERTLLDFF785 (Fig.
3A), which is similar to the
putative PCNA-binding motifs of several archaeal Pol B homologs
predicted by Ishino and colleagues (22). Glutathione S-transferase
(GST) fusion proteins were constructed for two overlapping fragments
containing the carboxyl-terminal region of Pa-Pol B3 (C1:
amino acids 612-785, C2: amino acids 726-785, Fig. 3,
A and B). In the pull-down affinity bead
interaction assays, GST alone had no detectable binding to either of
the Pa-PCNAs (Fig. 3C, lanes 2 and
6). However, binding to Pa-PCNA1 was detected with both of the GST-Pa-Pol B3 fusions (Fig. 3C,
lanes 3 and 4). In addition, a weak binding to
Pa-PCNA2 was also detected (Fig. 3C, lanes
7 and 8). The observed preferred binding to
Pa-PCNA1 by the carboxyl-terminal region of
Pa-Pol B3 provides evidence for an in vivo direct
interaction between Pa-Pol B3 and Pa-PCNA1.
In Vitro Direct Binding of Pa-UDGa and Pa-FEN to Pa-PCNA1--
A
GST fusion protein with Pa-UDGa was constructed for the
study of in vitro direct binding of Pa-UDGa to
two recombinant Pa-PCNA homologs using the pull-down
affinity bead interaction assay (Fig. 4A, lane 3).
Pa-FEN, which was predicted to be a PCNA-binding protein
based on previous studies (27), was also included for the binding
experiment (Fig. 4A, lane 4). Although GST alone
bound to neither Pa-PCNA (Fig. 4B, lanes
3 and 4), both GST-Pa-UDGa and
GST-Pa-FEN bound to Pa-PCNA1 (Fig. 4B,
lanes 5 and 7). Binding to Pa-PCNA2 was not
detected with either GST fusion (Fig. 4B, lanes 6 and 8). Therefore, the observed binding of
Pa-UDGa and Pa-FEN to Pa-PCNA1
provides evidence for a direct in vivo interaction between
Pa-UDGa-Pa-PCNA1 and
Pa-FEN-Pa-PCNA1. The effect of NaCl concentration
on the formation of a complex between Pa-UDGa and Pa-PCNA1 was studied. Binding was detected in the presence
of 0.05-0.4 M NaCl and was disrupted at NaCl
concentrations higher than 0.4 M (Fig. 4, C and
D). The effect of temperature on the formation of the
complex was also studied. When using a recombinant hexahistidine-tagged
Pa-UDGa and a recombinant Pa-PCNA1 in its native
form without any tag, binding was observed at 4 °C and was largely
retained after a 5-min treatment at 70 °C (Fig. 4E, lanes 3 and 4). Under the same experimental
conditions, the recombinant Pa-PCNA1 protein alone had no
detectable binding to the Ni2+-NTA resin (data not shown).
Binding of Pa-UDGa and Pa-FEN to the eukaryotic
murine PCNA was also tested but was undetectable under our experimental
conditions (data not shown).
The PCNA Interaction Motif Is Located near the Carboxyl Terminus of
Pa-UDGa--
The interaction between Pa-UDGa and
Pa-PCNA1 was further verified by identifying the specific
regions on Pa-UDGa required for PCNA binding. First,
three GST fusion proteins that contain various regions of
Pa-UDGa were constructed and tested for Pa-PCNA1 binding activity using the pull-down affinity bead interaction assay
(Fig. 5A).
GST-Pa-UDGa (amino acids 1-182) did not bind to
Pa-PCNA1, and this fusion protein had an excessive
proteolytic degradation (data not shown). However, both GST fusion
proteins containing the carboxyl-terminal region of Pa-UDGa
displayed binding activity (data not shown for GST-Pa-UDGa
(amino acids 131-196); see Fig. 5, C and D,
lane 8 for GST-Pa-UDGa (amino acids 172-196)). These results demonstrate that the 25-amino acid region near the Pa-PCNA1 carboxyl terminus is required for PCNA binding.
Next, Pa-UDGa mutants with specific substitutions within the
above identified 25-amino acid region were generated to identify amino
acid residues critical for PCNA binding activity. Previous studies have
shown that many PCNA-binding proteins contain the consensus
PCNA-binding motif QXX(L/M/I)XX(F/Y/H)(F/Y), and
mutational analysis indicates that the two consecutive hydrophobic
amino acid residues within this motif are involved in the interaction with PCNA (36). Analysis of the Pa-UDGa amino acid sequence revealed two putative PCNA-binding motifs near the carboxyl terminus of
Pa-UDGa (Fig. 5B). The sequence for the first
region is 177QKDLAMFF184 (motif 1), which
contains the eukaryotic PCNA-binding consensus sequence
QXXLXXFF. The sequence for the second region is
185GGGLDRFL192 (motif 2), which contains two
consecutive hydrophobic amino acid residues (Phe191 and
Leu192) closer to the carboxyl terminus (Fig.
5B). Two Pa-UDGa mutants were generated for the
pull-down binding assay, each with two amino acid changes in the
putative PCNA-binding motif 1 (F183A/F184A) or motif 2 (F191A/L192A). A
Pa-FEN mutant carrying the F345A/F346A modification in its
putative PCNA-binding motif 339TSSLDSFF346 near
its carboxyl terminus was also included in the experiment (Fig.
5B). As expected, the Pa-FEN mutant carrying
F345A/F346A failed to bind to Pa-PCNA1 (Fig. 5, C
and D, lane 4). The Pa-UDGa mutant
carrying F183A/F184A in the putative binding motif 1 was still capable
of binding to Pa-PCNA1 (Fig. 5, C and
D, lane 6). However, the binding was largely
abolished in the Pa-UDGa mutant carrying F191A/L192A in the
putative motif 2 (Fig. 5, C and D, lane
7). These results show that Phe345 and
Phe346 of Pa-FEN, and Phe191 and
Leu192 of Pa-UDGa are necessary for the binding
of Pa-FEN and Pa-UDGa to Pa-PCNA1.
With the goal of finding new archaeal PCNA-binding
proteins, we searched the predicted protein sequences of the P. aerophilum genome with identified putative PCNA-binding motifs
using MACPATTERN 3.6 (37). In this way, Pa-UDGa was
identified as a putative PCNA-binding protein. We carried out in
vitro biochemical analysis of Pa-UDGa binding to two
putative P. aerophilum PCNA homologs, Pa-PCNA1
and Pa-PCNA2, using the pull-down affinity bead interaction assay. Our results show that Pa-UDGa preferentially binds to
Pa-PCNA1 to form a thermostable protein complex. Apparently,
the binding between Pa-UDGa and Pa-PCNA1 is
specific as Pa-UDGa has no detectable binding to the murine
PCNA. Two consecutive hydrophobic amino acid residues,
Phe191 and Leu192, located near the carboxyl
terminus of Pa-UDGa, are crucial for PCNA binding activity.
Maintaining these same experimental conditions, the interactions
between Pa-PCNA1 and two other P. aerophilum proteins, Pa-FEN (wild type and mutant
F345A/F346A) and the carboxyl-terminal region of Pa-Pol B3,
provides evidence for Pa-PCNA1 as a functional PCNA homolog
in P. aerophilum. At this point, we were unable to perform
in vivo experiments to verify the physiological significance of the PCNA binding property of Pa-UDGa due to the current
lack of a genetic system in P. aerophilum. However,
identification of Pa-UDGa as an archaeal PCNA-binding
protein and its critical amino acid residues for PCNA binding is the
first step in revealing its biological significance in future genetic analyses.
The PCNA binding activity observed in Pa-UDGa from this
study and in hUNG2 from previous studies (19) raises the possibility that Pa-UDGa may be a functional analog of hUNG2.
Pa-UDGa and hUNG2 belong to two distinct UDG families due to
the low sequence similarity between them (31, 38). In addition,
Pa-UDGa is an olive green-colored protein (31) due to the
presence of an iron-sulfur cluster (39), whereas hUNG2 is largely
colorless. Despite these differences, both Pa-UDGa and hUNG2
have similar uracil glycosylase activities, and both interact with PCNA
through specific binding domains at either the carboxyl-terminal region (for Pa-UDGa) or the amino-terminal region (for hUNG2, 19).
Thus, it is possible that Pa-UDGa may be a functional analog
of hUNG2 for PCNA-dependent postreplicative removal of
misincorporated uracil (19, 20).
At this point, two or three putative PCNA homologs have been identified
in the completely sequenced Crenarchaeota genomes, including P. aerophilum, S. solfataricus, and Aeropyrum
pernix (21, 23). The presence of more than one PCNA homolog may
reflect either functional redundancy or functional differentiation.
Previous experiments with S. solfataricus SsoPCNA A
(039p) and SsoPCNA B (048p) demonstrate that both SsoPCNA homologs are
processivity factors for the single-subunit family B DNA polymerase
(Pol B1) despite their slightly different efficiencies (21). Our study with Pa-PCNA1 and Pa-PCNA2 suggests a possible
functional differentiation between two Pa-PCNA homologs.
Binding to Pa-UDGa and Pa-FEN is only detected
with Pa-PCNA1. Similarly, the carboxyl-terminal region of
Pa-Pol B3 also preferentially binds to Pa-PCNA1.
Although we cannot eliminate the possibility that the recombinant
Pa-PCNA2 is somehow inactivated under our experimental
conditions, regardless of its heat stability and weak binding to the
carboxyl-terminal region of Pa-Pol B3, our results suggest
that Pa-PCNA1 may be the major protein with functions
similar to PCNA in eukaryotes. Whether Pa-PCNA2 is
functional, and if so, which proteins it might interact with, remains
to be answered. Our experiments do not rule out the possibility that
Pa-PCNA1 and Pa-PCNA2 monomers may combine to
make functional heteromeric trimers.
Although FEN homologs are present in Archaea and Eukarya (27),
Pa-UDGa family members are found in Archaea and Eubacteria (38, 40). The amino acid sequence alignments of the carboxyl-terminal regions of FEN and UDG homologs are shown in Fig.
6. Although the conserved PCNA-binding
motif QXXLXX(F/W)F was observed near the carboxyl
terminus for almost all archaeal FEN homologs (Fig. 6A; see
also Ref. 27), divergent carboxyl-terminal sequences were observed for
archaeal UDG homologs (Fig. 6B). Only four homologs contained recognizable PCNA-binding motifs: Ape-UDG from
A. pernix, Sso-UDG1 from S. solfataricus, Af-UDG from Archaeoglobus
fulgidus, and Halo-UDG from Halobacterium
sp. NRC-1. Biochemical experiments will be required to test these
binding motifs and to determine whether the remaining archaeal
homologs also bind PCNA.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit of DNA polymerase
III holoenzyme, is present in bacteria (10, 11). More than a dozen
classes of eukaryotic PCNA-binding proteins have been shown to interact
with the PCNA sliding clamp, linking PCNA to several important
biological processes beyond DNA replication, such as DNA repair and
cell cycle regulation (12-18). In many cases, PCNA binding partners
interact with PCNA through a conserved motif identified as
QXX(L/M/I)XX(F/Y/H)(F/Y) that is usually located
near either the amino or the carboxyl terminus. One important example
of a eukaryotic PCNA-binding protein involved in DNA repair is human
major nuclear uracil-DNA glycosylase (hUNG2), which removes uracil from
misincorporated dUMP residues in an immediate postreplicative process
(19, 20). hUNG2 interacts with PCNA through its PCNA binding
site, 4QKTLYSFF11, which is located near the
amino terminus of hUNG2.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside during mid-log
growth phase for 3 h at 37 °C. The plasmid pREP4 constitutively
expresses the Lac repressor protein encoded by the lacI gene
to reduce the basal level of expression (Qiagen). Cells were lysed in
buffer A (20 mM Tris-HCl, pH 7.4, 60 mM NaCl, and 2 mM EDTA supplemented with 0.2 mg/ml lysozyme and 1 mM phenylmethylsulfonyl fluoride) by sonication. The cell
lysates were clarified by centrifugation at 15,000 × g
for 30 min. The protein concentration was determined by Bradford
protein assay (Bio-Rad). The cell lysates were stored as small aliquots
at
80 °C. Partial purification of Pa-PCNA1 and
Pa-PCNA2 was obtained by heat treatment of 200 µl of cell lysates at 70 °C for 10 min followed by centrifugation at
15,000 × g for 30 min. The supernatant was stored at
80 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (103K):
[in a new window]
Fig. 1.
Sequence alignment of
Pa-PCNA1, Pa-PCNA2, and characterized
eukaryotic and archaeal PCNA homologs using the program ClustalW (41)
(A) and percentage of sequence identity among PCNA
homologs shown in panel A (B).
The homologs are the following (organisms and the Protein Data Bank
accession numbers in parentheses): Hsa-PCNA (Homo
sapiens, P12004); Spo-PCNA (Schizosaccharomyces
pombe, CAB38513); Pfu-PCNA (P. furiosus,
BAA33020); Pa-PCNA1 (P. aerophilum
PCNA1, AAL64629); Sso-PCNA A (039p) (S. solfataricus, P57765); Pa-PCNA2 (P. aerophilum, AAL62977); Sso-PCNA B (048p)
(S. solfataricus, P57766). Black boxes indicate
70-100% amino acid residue identity, and gray boxes
indicate 70-100% similarity. The asterisks mark amino acid
residues corresponding to those forming the hydrophobic pocket in
human PCNA (17, 23).

View larger version (93K):
[in a new window]
Fig. 2.
Partial purification of recombinant
Pa-PCNA1 and Pa-PCNA2. The
arrows mark full-length recombinant proteins. A,
SDS-PAGE analysis of crude E. coli lysates containing
hexahistidine-tagged Pa-PCNA1 and hexahistidine-tagged
Pa-PCNA2 before the heat treatment (4 °C) and after the
heat treatment (70 °C). Vector, pQE30 without insert
(lanes 1 and 2); Pa-PCNA1,
pQE30Pa-PCNA1 (lanes 3 and 4);
Pa-PCNA2, pQE30Pa-PCNA2 (lanes 5 and
6); and mPCNA, pQE30murinePCNA (expresses
hexahistidine-tagged murine PCNA, lanes 7 and 8).
The crude E. coli lysates were prepared as described under
"Experimental Procedures," subjected to SDS-PAGE, and visualized by
Coomassie Blue staining. B, Western blot analysis of the SDS
gel shown in panel A. The Western blotting procedure was
performed as described under "Experimental Procedures."

View larger version (38K):
[in a new window]
Fig. 3.
In vitro direct binding between
Pa-PCNA1 and the carboxyl-terminal region of
Pa-Pol B3. A, schematic diagram of
Pa-Pol B3 and the two fragments (C1 and C2). B,
SDS-PAGE analysis of the following samples: GST (lane 2),
GST-Pol B3 (C1, amino acids 612-785) (lane 3), and GST-Pol
B3 (C2, amino acids 726-785) (lane 4). Lane M
contains molecular mass standards (Bio-Rad) as indicated on the
left. The protein bands were visualized by Coomassie Blue
staining. C, Western blot analysis of the samples from the
pull-down experiment: inputs of Pa-PCNA1 and
Pa-PCNA2 (lanes 1 and 5); GST alone
with Pa-PCNA1 and Pa-PCNA2 (lanes 2 and 6); GST-Pol B3 (C1) with Pa-PCNA1 and
Pa-PCNA2 (lanes 3 and 7); GST-Pol B3
(C2) with Pa-PCNA1 and Pa-PCNA2 (lanes
4 and 8). Sample preparation and Western blot analysis
are described under "Experimental Procedures."

View larger version (42K):
[in a new window]
Fig. 4.
In vitro direct binding of
Pa-UDGa and Pa-FEN to
Pa-PCNA1, the effect of NaCl concentration and
temperature. A, SDS-PAGE analysis of the following
samples: GST (lane 2), GST-Pa-UDGa (lane
3), and GST-Pa-FEN (lane 4). Lane
M contains molecular mass standards (Bio-Rad) as indicated on the
left. The protein bands were visualized by Coomassie Blue
staining. B, Western blot analysis of the samples from the
pull-down experiment: inputs of Pa-PCNA1 and
Pa-PCNA2 (lanes 1 and 2); GST alone
with Pa-PCNA1 and Pa-PCNA2 (lanes 3 and 4); GST-Pa-UDGa with Pa-PCNA1 and
Pa-PCNA2 (lanes 5 and 6);
GST-Pa-FEN with Pa-PCNA1 and Pa-PCNA2
(lanes 7 and 8). C, Western blot
analysis of the samples from the pull-down experiment of
GST-Pa-UDGa with Pa-PCNA1 in the presence of
varying amounts of NaCl as indicated. The position of
Pa-PCNA1 was marked on the right. D,
SDS-PAGE analysis of the amount of full-length GST-Pa-UDG
fusion protein used in the pull-down experiment shown in panel
C. The protein bands were visualized by Coomassie blue staining.
The position of the full-length GST-Pa-UDGa was marked on
the right. E, thermostable binding between
Pa-UDGa and Pa-PCNA1. SDS-PAGE of the following
samples from the pull-down experiment: input of
Pa-PCNA1 without any tag (lane 2);
His6-tagged Pa-UDGa with Pa-PCNA1
without 70 °C treatment (lane 3) and with 70 °C
treatment (lane 4). The protein bands were visualized by
Coomassie blue staining. Lane M contains molecular mass
standards (Bio-Rad) as indicated on the left. Sample
preparation and Western blot analysis are described under
"Experimental Procedures."

View larger version (33K):
[in a new window]
Fig. 5.
PCNA binding activity of the
carboxyl-terminal region of Pa-UDGa.
A, schematic diagram summarizing the results of the PCNA
binding assays with GST fusions containing different Pa-UDGa
amino acid segments as indicated. B, schematic diagrams of
the Pa-UDGa and Pa-FEN proteins. The putative
PCNA-binding motifs located at the carboxyl-terminal region of
Pa-UDGa and Pa-FEN are indicated. C
and D, SDS-PAGE analysis (C) and Western blot
analysis (D) of the following samples from the pull-down
experiment: input of Pa-PCNA1 (lane 1); GST alone
with Pa-PCNA1 (lane 2); GST-wild type
Pa-FEN (WT, lane 3) and GST-mutant
Pa-FEN F345A/F346A (FF
AA, lane 4)
with Pa-PCNA1; GST-wild-type Pa-UDGa (WT,
lane 5) and three GST-Pa-UDGa mutants with
Pa-PCNA1: F183A/F184A (FF
AA, lane
6); F191A/L192A (FL
AA, lane 7), and
carboxyl-terminal (amino acids 172-196, lane 8). The
position of Pa-PCNA1 was marked on the right. The
molecular mass standards (Bio-Rad) are indicated on the
left. Sample preparation and Western blot analysis are
described under "Experimental Procedures."
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (52K):
[in a new window]
Fig. 6.
Sequence alignment of the carboxyl-terminal
regions of archaeal FEN homologs and archaeal UDG homologs using the
ClustalW program (41). Black boxes indicate 70-100%
amino acid identity, and gray boxes indicate 70-100% amino
acid similarity. A, carboxyl-terminal region of FEN. The
asterisks mark the proposed PCNA-binding motif (27).
The symbol (
) marks a eukaryotic FEN homolog. The homologs are the
following (organisms and the Protein Data Bank accession numbers in
parentheses): Tv-FEN (Thermoplasma volcanium,
BAB59701; Ta-FEN (Thermoplasma acidophilum,
CAC12164); Ape-FEN (A. pernix, BAA79026);
Sso-FEN (S. solfataricus, AAK40525);
Pa-FEN (P. aerophilum, AAL62961);
Af-FEN (A. fulgidus, AAB90967);
Pab-FEN (Pyrococcus abyssi, CAB49654);
Ph-FEN (Pyrococcus horikoshii,
BAA30521); Mj-FEN (Methanococcus jannaschii,
AAB99454); Mth-FEN (Methanobacterium
thermoautotrophicum, AAB86106); Halo-FEN
(Halobacterium sp. NRC-1, AAG19690); and Hsa-FEN
(Homo sapiens, AAH00323). B, carboxyl-terminal
region of UDG. The boxed amino acid residues are proposed to
be involved in PCNA interaction. The symbol (
) indicates a
eubacterial UDG homolog. The homologs are the following (organisms and
the Protein Data Bank accession numbers in parentheses):
Pa-UDGa (P. aerophilum, AAL62921);
Ape-UDG (A. pernix, BAA79385);
Sso-UDG1 (S. solfataricus, AAK42437);
Af-UDG (A. fulgidus, AAB88977);
Pab-UDG (P. abyssi, CAB49606); Ph-UDG
(P. horikoshii, BAA30579); Aa-UDG
(Aquifex aeolicus, AAC07559); Tm-UDG
(Thermotoga maritima, AAD35596); Tp-UDG
(Treponema pallidum, AAC65215); Halo-UDG
(Halobacterium sp. NRC-1, AAG20230); Ta-UDG
(T. acidophilum, CAC11619); and Tv-UDG (T. volcanium, BAB59983).
| |
FOOTNOTES |
|---|
* This work was supported by National Research Service Award No. T32 CA09056 from the United States Health and Human Services Institutional (to H. Y.), by Grant GM 57917 from the National Institutes of Health (to J. H. M.) and by the generous financial support of the Union Bank of Switzerland Stiftung (to A. A. S).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Center for Astrobiology, Institute of
Geophysics and Planetary Physics, UCLA, Los Angeles, CA 90095.
Present address: Diversa, 4995 Directors Place, San Diego, CA
92121
** To whom correspondence should be addressed: Dept. of Microbiology and Molecular Genetics, 1602 Molecular Sciences Bldg., 405 Hilgard Ave., Los Angeles, CA 90095. Tel.: 310-825-8460; Fax: 310-206-3088; E-mail: jhmiller@mbi.ucla.edu.
Published, JBC Papers in Press, April 1, 2002, DOI 10.1074/jbc.M201820200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: PCNA, proliferating cell nuclear antigen; UDG, uracil-DNA glycosylase; Pa-UDGa, P. aerophilum UDGa; Pol B, family B DNA polymerase; Pa-Pol B3, P. aerophilum Pol B3; FEN, flap endonuclease; GST, glutathione S-transferase; Ni2+-NTA, nickel-nitrilotriacetic acid; Pa, P. aerophilum; hUNG2, human major nuclear uracil-DNA glycosylase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Kong, X. P., Onrust, R., O'Donnell, M., and Kuriyan, J. (1992) Cell 69, 425-437[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Krishna, T. S., Kong, X. P., Gary, S., Burgers, P. M., and Kuriyan, J. (1994) Cell 79, 1233-1243[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Moarefi, I., Jeruzalmi, D., Turner, J., O'Donnell, M., and Kuriyan, J. (2000) J. Mol. Biol. 296, 1215-1223[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Matsumiya, S.,
Ishino, Y.,
and Morikawa, K.
(2001)
Protein Sci.
10,
17-23 |
| 5. | Pisani, F. M., De, Felice, M., Carpentieri, F., and Rossi, M. (2000) J. Mol. Biol. 301, 61-73[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Oyama, T., Ishino, Y., Cann, I. K., Ishino, S., and Morikawa, K. (2001) Mol. Cell 8, 455-463[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Jeruzalmi, D., Yurieva, O., Zhao, Y., Young, M., Stewart, J., Hingorani, M., O'Donnell, M., and Kuriyan, J. (2001) Cell 106, 417-428[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Jeruzalmi, D., O'Donnell, M., and Kuriyan, J. (2001) Cell 106, 429-441[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Cann, I. K.,
Ishino, S.,
Yuasa, M.,
Daiyasu, H.,
Toh, H.,
and Ishino, Y.
(2001)
J. Bacteriol.
183,
2614-2623 |
| 10. | Hingorani, M. M., and O'Donnell, M. (2000) Curr. Biol. 10, R25-29[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Bruck, I., and O'Donnell, M. (2001) Genome Biol. 2, 3001.1-3001.3 |
| 12. | Kelman, Z., and Hurwitz, J. (1998) Trends Biochem. Sci. 23, 236-238[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Tsurimoto, T. (1999) Front. Biosci. 4, D849-858[Medline] [Order article via Infotrieve] |
| 14. | Krude, T. (1999) Curr. Biol. 9, R394-396[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Kolodner, R. D., and Marsischky, G. T. (1999) Curr. Opin. Genet. Dev. 9, 89-96[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Warbrick, E. (2000) Bioessays 22, 997-1006[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., and Kuriyan, J. (1996) Cell 87, 297-306[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Shamoo, Y., and Steitz, T. A. (1999) Cell 99, 155-166[CrossRef][Medline] [Order article via Infotrieve] |
| 19. | Otterlei, M., Warbrick, E., Nagelhus, T. A., Haug, T., Slupphaug, G., Akbari, M., Aas, P. A., Steinsbekk, K., Bakke, O., and Krokan, H. E. (1999) EMBO J. 18, 3834-3844[CrossRef][Medline] [Order article via Infotrieve] |
| 20. | Krokan, H. E., Otterlei, M., Nilsen, H., Kavli, B., Skorpen, F., Andersen, S., Skjelbred, C., Akbari, M., Aas, P. A., and Slupphaug, G. (2001) Prog. Nucleic Acid Res. Mol. Biol. 68, 365-386[Medline] [Order article via Infotrieve] |
| 21. | De Felice, M., Sensen, C. W., Charlebois, R. L., Rossi, M., and Pisani, F. M. (1999) J. Mol. Biol. 291, 47-57[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Cann, I. K.,
Ishino, S.,
Hayashi, I.,
Komori, K.,
Toh, H.,
Morikawa, K.,
and Ishino, Y.
(1999)
J. Bacteriol.
181,
6591-6599 |
| 23. | Iwai, T., Kurosawa, N., Itoh, Y. H., and Horiuchi, T. (2000) Extremophiles 4, 357-364[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Fitz-Gibbon, S. T.,
Ladner, H.,
Kim, U. J.,
Stetter, K. O.,
Simon, M. I.,
and Miller, J. H.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
984-989 |
| 25. | Hwang, K. Y., Baek, K., Kim, H. Y., and Cho, Y. (1998) Nat. Struct. Biol. 5, 668-670[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Hosfield, D. J., Mol, C. D., Shen, B., and Tainer, J. A. (1998) Cell 95, 135-146[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Hosfield, D. J.,
Frank, G.,
Weng, Y.,
Tainer, J. A.,
and Shen, B.
(1998)
J. Biol. Chem.
273,
27154-27161 |
| 28. |
Rao, H. G.,
Rosenfeld, A.,
and Wetmur, J. G.
(1998)
J. Bacteriol.
180,
5406-5412 |
| 29. |
Matsui, E.,
Kawasaki, S.,
Ishida, H.,
Ishikawa, K.,
Kosugi, Y.,
Kikuchi, H.,
Kawarabayashi, Y.,
and Matsui, I.
(1999)
J. Biol. Chem.
274,
18297-18309 |
| 30. |
Völkl, P.,
Huber, R.,
Drobner, E.,
Rachel, R.,
Burggraf, S.,
Trincone, A.,
and Stetter, K. O.
(1993)
Appl. Environ. Microbiol.
59,
2918-2926 |
| 31. |
Sartori, A. A.,
Schar, P.,
Fitz-Gibbon, S.,
Miller, J. H.,
and Jiricny, J.
(2001)
J. Biol. Chem.
276,
29979-29986 |
| 32. | Fitz-Gibbon, S., Choi, A. J., Miller, J. H., Stetter, K. O., Simon, M. I., Swanson, R., and Kim, U. J. (1997) Extremophiles 1, 36-51[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Lebel, M.,
Spillare, E. A.,
Harris, C. C.,
and Leder, P.
(1999)
J. Biol. Chem.
274,
37795-37799 |
| 34. | Ho, S. N., Hunt, H. D., Horten, R. M., Pullen, J. K., and Pease, L. R. (1989) Gene 77, 51-59[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Zhang, P., Zhang, S.-J., Zhang, Z., Woessner, J. F., Jr., and Lee, M. Y. W. T. (1995) Biochemistry 34, 10703-10712[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Haracska, L.,
Johnson, R. E.,
Unk, I.,
Phillips, B.,
Hurwitz, J.,
Prakash, L.,
and Prakash, S.
(2001)
Mol. Cell Biol.
21,
7199-7206 |
| 37. |
Fuchs, R.
(1994)
Comput. Appl. Biosci.
10,
171-178 |
| 38. | Sandigursky, M., and Franklin, W. A. (1999) Curr. Biol. 9, 531-534[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
Hinks, J. A.,
Evans, M. C., De,
Miguel, Y.,
Sartori, A. A.,
Jiricny, J.,
and Pearl, L. H.
(2002)
J. Biol. Chem.
277,
16936-16940 |
| 40. |
Sandigursky, M.,
and Franklin, W. A.
(2000)
J. Biol. Chem.
275,
19146-19149 |
| 41. |
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680 |
This article has been cited by other articles:
![]() |
X. Liu, S. Choudhury, and R. Roy In Vitro and in Vivo Dimerization of Human Endonuclease III Stimulates Its Activity J. Biol. Chem., December 12, 2003; 278(50): 50061 - 50069. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Sartori and J. Jiricny Enzymology of Base Excision Repair in the Hyperthermophilic Archaeon Pyrobaculum aerophilum J. Biol. Chem., June 27, 2003; 278(27): 24563 - 24576. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |